Sponsor or institution
Clinical trials and research at Enfuego Therapeutics INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Overcoming KRAS Drug Resistance with Targeted KRAS-G12V and TEAD Chimeras
This grant aims to develop a targeted approach to treat KRAS-driven cancers by combining mutant KRAS targeting with TEAD pathway engagement to overcome resistance.
-
Therapy targeting KRAS G12V mutations in lung, colon, and pancreatic cancers
Developing a precision RNA-based therapy that aims to shut off the KRAS G12V mutation in people whose tumors are driven by that change.
-
Targeting specific KRAS mutations in cancer treatment
This study is exploring new treatments for people with aggressive cancers like lung, colon, and pancreatic cancer that have a specific mutation called KRAS G12V, using a special technique to target and turn off the bad gene while keeping healthy cells safe.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.